Anti-RAI2 monoclonal antibody

Pre-made anti-RAI2 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to RAI2/RAI2 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP2691-Ab-1/ GM-Tg-hg-IP2691-Ab-2Anti-Human RAI2 monoclonal antibodyHuman
GM-Tg-rg-IP2691-Ab-1/ GM-Tg-rg-IP2691-Ab-2Anti-Rat RAI2 monoclonal antibodyRat
GM-Tg-mg-IP2691-Ab-1/ GM-Tg-mg-IP2691-Ab-2Anti-Mouse RAI2 monoclonal antibodyMouse
GM-Tg-cynog-IP2691-Ab-1/ GM-Tg-cynog-IP2691-Ab-2Anti-Cynomolgus/ Rhesus macaque RAI2 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP2691-Ab-1/ GM-Tg-felg-IP2691-Ab-2Anti-Feline RAI2 monoclonal antibodyFeline
GM-Tg-cang-IP2691-Ab-1/ GM-Tg-cang-IP2691-Ab-2Anti-Canine RAI2 monoclonal antibodyCanine
GM-Tg-bovg-IP2691-Ab-1/ GM-Tg-bovg-IP2691-Ab-2Anti-Bovine RAI2 monoclonal antibodyBovine
GM-Tg-equg-IP2691-Ab-1/ GM-Tg-equg-IP2691-Ab-2Anti-Equine RAI2 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP2691-Ab-1/ GM-Tg-hg-IP2691-Ab-2; GM-Tg-rg-IP2691-Ab-1/ GM-Tg-rg-IP2691-Ab-2;
GM-Tg-mg-IP2691-Ab-1/ GM-Tg-mg-IP2691-Ab-2; GM-Tg-cynog-IP2691-Ab-1/ GM-Tg-cynog-IP2691-Ab-2;
GM-Tg-felg-IP2691-Ab-1/ GM-Tg-felg-IP2691-Ab-2; GM-Tg-cang-IP2691-Ab-1/ GM-Tg-cang-IP2691-Ab-2;
GM-Tg-bovg-IP2691-Ab-1/ GM-Tg-bovg-IP2691-Ab-2; GM-Tg-equg-IP2691-Ab-1/ GM-Tg-equg-IP2691-Ab-2
Products NameAnti-RAI2 monoclonal antibody
Formatmab
Target NameRAI2
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-RAI2 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP2691-Ag-1Recombinant multi-species RAI2 protein
    ORF Viral VectorvGMLP001146human RAI2 Lentivirus particle
    ORF Viral VectorpGMLP001146human RAI2 Lentivirus plasmid
    ORF Viral VectorpGMLPm005019mouse Rai2 Lentivirus plasmid
    ORF Viral VectorvGMLPm005019mouse Rai2 Lentivirus particle


    Target information

    Target IDGM-IP2691
    Target NameRAI2
    Gene ID10742,24004,501555,693329,100685169,101099182,539414,100051458
    Gene Symbol and Synonyms3f8,RAI2,RGD1560139
    Uniprot AccessionQ9Y5P3
    Uniprot Entry NameRAI2_HUMAN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000131831
    Target ClassificationN/A

    The target: RAI2, gene name: RAI2, also named as . Retinoic acid plays a critical role in development, cellular growth, and differentiation. The specific function of this retinoic acid-induced gene has not yet been determined but it may play a role in development. The chromosomal location of this gene designates it to be a candidate for diseases such as Nance-Horan syndrome, sensorineural deafness, non-specific X-linked cognitive disability, oral-facial-digital syndrome, and Fried syndrome. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Feb 2010].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.